First Slide
Accelerating drug development from lab to patient, quickly and efficiently.

Venn Life Sciences offers drug development consultancy and services to help bring products to the market quickly and efficiently.

Second Slide
About Us

A trusted partner in the life science industry for over 25 years.

Contact Us

Get in touch and see how we can help you with your clinical trial management and resourcing options.

previous arrow
next arrow

Your drug development partner. From start to finish.

We uniquely combine drug development consultancy, clinical trial design and execution, helping save time and money in bringing products to market whilst achieving project milestone objectives across the entire product life cycle.
More About Venn
Our Services

Infinite possibilities for drug development.

Over 25 years, we have built up substantial therapeutic and study experience, contributing to the efficient management of sites, budgets and communication channels. Venn is renowned for its hands-on approach and consistent delivery of high quality work on time and on budget.

Our services cover all stages of the drug development journey, from Discovery through to Market Authorisation and all phases in-between.
Stages of the drug development journey:
  • Discovery
  • Pre-clinical
  • Phase 1
  • Phase 2
  • Phase 3
  • Market Authorisation

This enables us to create, plan and execute drug development programmes effectively for our global customers, ranging from virtual start-up companies to established pharma companies. Venn’s capabilities and expertise includes CMC, Non-Clinical, Clinical Pharmacology and Development, Statistics, Study Design and Methodology, Data Management, RTSM...


In drug development, a proper clinical development strategy, implemented at an early stage of product development, helps to guide the success (and cost-effectiveness) of the product development. To understand the kinetics of a drug in terms of absorption, distribution, metabolism and elimination (ADME), pharmacokinetic...


Non-clinical testing is conducted throughout all phases of drug development to assess the safety profile and pharmacokinetic/toxicokinetic (PK/TK) characteristics of drug candidates. If performed well, it can identify key ‘knock-out’ criteria, maximizing the chances of success in subsequent stages of development. Strategies for the...


In order to ensure a good development trajectory for your potential drug compound a good understanding of the drug development process is indispensable. Each step in the process is linked to others and a large variety of expertise is typically involved for tackling all...


The project management of early development (phase 1/2a) trials requires a well thought and specific approach. Phase 1 trials form the basis of your further development, a well-executed phase 1 trial is therefore key to the further success of your compound. As an independent...


Venn Data Management services/capabilities span the data life cycle from collection to archival. Data drives the whole clinical development process. A high-quality dataset is therefore essential for the success of your drug. Our clinical data managers provide a smooth less flow from first patient...


By offering tailor made solutions with a strong focus on accuracy and quality, our clients can keep a track on timelines and costs are kept to a minimum. Our statisticians provide statistical support along the full development cycle of the drug, from early development...


To appropriately manufacture a pharmaceutical or biological product, a well-defined drug substance and product, manufacturing process and test methods must be developed in order to ensure that the product is safe, effective and consistent between batches. Which is a prerequisite to get regulatory approval...


From the early phases of development through marketing authorisation, regulatory interactions are essential to your progress and success. These exchanges will not only shape the advancement of your program, but also the value of your asset and your company. When you are planning your...

Support of Venn on human dose prediction including designing of preclinical pharmacology experiments and subsequent execution of MABEL calculation played a pivotal role in obtaining TGA’s approval of client’s first-in-human trial in Australia.”


European biotech company

Working with Venn has been a great experience. The Venn team is collaborative, responsive and flexible and produce work to a very high standard.”

Professor Elizabeth Ashley

University of Oxford

We have been delighted with the work produced by the Venn Life Sciences team to date. We look forward to further collaborations with Venn on future projects.”

Jeremy Skillington

PhD, CEO of Poolbeg Pharma

We have been delighted to work with Venn Life Sciences on a complex clinical trial.”

Professor Keith G. Oldroyd

Director of Research and Development at Golden Jubilee National Hospital

We have been working with Venn Life Sciences for several years on two compounds requiring sophisticated formulation development work.”

Akinori Arimura, PhD

Director of Clinical Development at Carna Biosciences, Inc.

I highly appreciated the flexibility of Vennlife to provide a custom PK analysis with a very short timeline.”

Jonathan Back

Director of Translational Research at GlycoEra AG in Schlieren, Switzerland

Events & Courses

View more

Latest on LinkedIn

Ready to see how Venn Life Sciences could speed up your drug development program?
Get in touch.

Contact Venn
Venn is part of hVIVO plc. hVIVO is the world leader in testing infectious and respiratory disease vaccines and antivirals using human challenge clinical trials. Read more